Clinical Trials on Hepatitis C (HCV) in New Zealand
Total 2656 results
-
Gilead SciencesCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Trek Therapeutics, PBCCompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral InfectionUnited States, New Zealand
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
Hoffmann-La RocheCompletedHepatitis C, Chronic, Healthy VolunteerNew Zealand
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Antipodean Pharmaceuticals, Inc.Completed
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Gilead SciencesCompletedHCV InfectionUnited States, Germany, New Zealand
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Australia, Belgium, Canada, France, New Zealand, Singapore, South Africa, Vietnam
-
Enanta Pharmaceuticals, IncNovotech (Australia) Pty LimitedCompletedHepatitis CNew Zealand
-
Vertex Pharmaceuticals IncorporatedCompleted
-
Novartis PharmaceuticalsTerminated
-
AbbVie (prior sponsor, Abbott)CompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV)United States, Australia, Canada, France, Germany, New Zealand, Puerto Rico, Spain, United Kingdom
-
Syneos HealthF-star Therapeutics, Inc.CompletedHepatitis C InfectionAustralia, New Zealand
-
Alios Biopharma Inc.CompletedChronic Hepatitis CNew Zealand, Moldova, Republic of, Mauritius, United Kingdom
-
Alios Biopharma Inc.Vertex Pharmaceuticals IncorporatedTerminatedHepatitis C, ChronicAustralia, New Zealand
-
Gilead SciencesCompletedHCV InfectionUnited States, New Zealand, Germany
-
AbbVie (prior sponsor, Abbott)CompletedHepatitis C | Chronic Hepatitis C Infection | HCV | Hepatitis C Genotype 1United States, Puerto Rico
-
Hepatitis Resource NetworkHoffmann-La RocheUnknownHIV Infections | Chronic Hepatitis C Infection in HIV Infected PersonsUnited States
-
Presidio Pharmaceuticals, Inc.CompletedHepatitis C, ChronicUnited States, Australia, New Zealand
-
Gilead SciencesCompletedPost Liver Transplant | Recurrent Chronic Hepatitis C VirusUnited States, Spain, New Zealand, France, Germany
-
Kirby InstituteAbbVieCompletedHepatitis C, AcuteUnited Kingdom, Australia, New Zealand
-
Gilead SciencesCompleted
-
Gilead SciencesCompletedHepatitis C VirusUnited States, New Zealand
-
Vertex Pharmaceuticals IncorporatedTerminatedChronic Hepatitis C Virus InfectionUnited States, New Zealand
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1United States
-
Hoffmann-La RocheCompletedHepatitis C, ChronicUnited States, Canada, Slovakia, Poland, New Zealand, France, Australia
-
Saint Michael's Medical CenterCompletedHIV Infection | Hepatitis C InfectionUnited States
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionTerminatedHCV InfectionUnited States, Germany, Netherlands
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Canada, Germany, Greece, Italy, Korea, Republic of, Poland, Puerto Rico, Spain, Sweden
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Belgium, Canada, Germany, Japan, Puerto Rico, Russian Federation, Spain, United Kingdom
-
Gilead SciencesCompletedChronic HCV InfectionBelgium, Austria, New Zealand, United Kingdom, Germany, Spain, Netherlands, France, Switzerland, Canada, Australia, Italy
-
Gilead SciencesCompletedChronic Hepatitis C VirusUnited States, Puerto Rico
-
Macfarlane Burnet Institute for Medical Research...St Vincent's Hospital MelbourneCompletedHepatitis CAustralia, New Zealand
-
Gilead SciencesTerminatedHCV InfectionUnited States, United Kingdom, Germany, Canada, Puerto Rico, Poland
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
Kirby InstituteCompletedDAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) (DARE-C II)Hepatitis CAustralia, New Zealand
-
Kirby InstituteActive, not recruitingHepatitis C | HIV | HIV-HCV CoinfectionAustralia
-
Hoffmann-La RocheCompletedHepatitis C, ChronicFrance, Germany, United States, New Zealand
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Bulgaria, Canada, Czechia, France, Greece, Hungary, Ireland, Israel, Italy, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, United Kingdom, Vietnam
-
Janssen Scientific Affairs, LLCCompleted
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Puerto Rico
-
Rockefeller UniversityTerminatedHIV Infections | Hepatitis C VirusUnited States
-
Gilead SciencesCompletedHCV InfectionNew Zealand, United States, Puerto Rico